Agarwood, as a precious medicinal material with distinctive characteristics from Hainan, has been shown in recent studies to possess significant anti-inflammatory and antibacterial properties. With the rapid growth in public recognition of health concepts, oral health has garnered increased attention. The main focus of this study is the impact of agarwood extracts on the oral-gut axis microbiota. The relationship between the oral and gut microbiota is closely intertwined, where oral microbiota can directly colonize the intestine via saliva and other means, altering the original microbial composition of the gut and leading to dysbiosis. For instance, Porphyromonas gingivalis significantly increases in patients with gingivitis and periodontitis, as it can tolerate the acidic environment of the stomach and colonize the intestines through the gastric barrier. Therefore, oral health can affect intestinal health. Additionally, oral lesions are evident in patients with intestinal inflammation; such patients, like those with IBD, exhibit a significant accumulation of oral bacteria in the intestines. Although IBD primarily affects the intestines, its extraintestinal symptoms, often prominently displayed, include oral manifestations. Hence, intestinal health can also influence oral health. Agarwood extracts inhibit pathogenic oral microbiota, impedes their colonization in the intestine, and consequently reduces the likelihood of inflammatory bowel disease.. This article, by introducing the microbiota of periodontitis and the pathogenesis of inflammatory bowel disease, along with extraintestinal symptoms, the preventive and inhibitory mechanisms of agarwood extract on the associated microbiota are analyzed, providing new insights for the treatment of such patients. It underscores the importance of maintaining oral hygiene and preventing oral diseases as well.
Published in | Science Journal of Public Health (Volume 12, Issue 3) |
DOI | 10.11648/j.sjph.20241203.13 |
Page(s) | 79-82 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Agarwood, Oral-Gut Axis Microbiota, Inflammation, Periodontitis, Inflammatory Bowel Disease
[1] | Kitamoto, S., Nagao-Kitamoto, H., Hein, R., Schmidt, T. M., & Kamada, N. (2020). The Bacterial Connection between the Oral Cavity and the Gut Diseases. Journal of Dental Research, 99(9), 1021-1029. |
[2] | Lourenço, T. G. B., Spencer, S. J., Alm, E. J., et al. (2018). Defining the gut microbiota in individuals with periodontal diseases: An exploratory study. Journal of Oral Microbiology, 10(1), 1487741. |
[3] | Arimatsu, K., Yamada, H., Miyazawa, H., et al. (2014). Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Scientific Reports, 4, 4828. |
[4] | Walker, M. Y., Pratap, S., Southerland, J. H., Farmer-Dixon, C. M., Lakshmyya, K., & Gangula, P. R. (2018). Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide, 73, 81-88. |
[5] | Tsukasaki, M., Komatsu, N., Nagashima, K., Nitta, T., Pluemsakunthai, W., Shukunami, C.,... Takayanagi, H. (2018). Host defense against oral microbiota by bone-damaging T cells. Nature Communications, 9(1), 701. |
[6] | Kitamoto, S., & Kamada, N. (2022). Periodontal connection with intestinal inflammation: Microbiological and immunological mechanisms. Periodontology 2000, 98, 142–153. |
[7] | Muhvic-Urek, M., Tomac-Stojmenovic, M., & Mijandrušic-Sincğic, B. (2016). Oral pathology in inflammatory bowel disease. World Journal of Gastroenterology, 22(25), 5655-5667. |
[8] | Gevers, D., Kugathasan, S., Denson, L., et al. (2014). The treatment-naive microbiome in new-onset Crohn's disease. Cell Host & Microbe, 15(3), 382-392. |
[9] | Dinakaran, V., Mandape, S. N., Shuba, K., et al. (2018). Identification of specific oral and gut pathogens in full thickness colon of colitis patients: implications for colon motility. Frontiers in Microbiology, 9, 3220. |
[10] | Ministry of Health of the People's Republic of China, Pharmacopoeia Committee. (1977). Pharmacopoeia of the People's Republic of China (Part 1). Beijing: People's Health Publishing House. |
[11] | Mei, W. L., Zeng, Y. B., Wu, J., et al. (2008). Chemical constituents and anti-MRSA activity of Chinese eaglewood essential oil. Chinese Pharmaceutical Journal (English Edition), 17(3), 225-229. |
[12] | Chen, H., Yang, Y., Xue, J., et al. (2011). Chemical constituents and antibacterial activity of chemically stimulated agarwood, wild agarwood, and healthy agarwood essential oils. Molecules, 16(6), 4884-4896. |
[13] | Hou, W. B., Li, W., Li, Q., et al. (2016). Research progress on saturated vapor pressure of turpentine system components. Chemical Technology & Development, 45(12), 14-18. |
[14] | Yang, L., Qiao, L. R., Xie, D., et al. (2012). Chemical constituents of indigenous agarwood in China. China Journal of Chinese Materia Medica, 37(13), 1973-1976. |
[15] | Dong, R. H., Gao, H. Z., Liu, Z. Y., et al. (2010). Research progress on biological activity of diterpenoids from Labiatae plants. China Pharmacy, 21(07), 651-653. |
[16] | Lin, L. D., & Qi, S. Y. (2000). Triterpenoid components in Chinese agarwood. China Herbal Medicine, (02), 11-12. |
[17] | Huo, H. X., Zhu, Z. X., Pang, D. R., et al. Anti-neuroinflammatory sesquiterpenes from Chinese eaglewood. |
[18] | Wang, S. L., Tsai, Y. C., Fu, S. L., Cheng, M. J., Chung, M. I., & Chen, J. J. (2018). 2-(2-Phenylethyl)-4H-chromen-4-one Derivatives from the Resinous Wood of Aquilaria sinensis with Anti-Inflammatory Effects in LPS-Induced Macrophages. Molecules, 23(2), 289. |
[19] | Zhao, H., Peng, Q., Han, Z., Yang, L., & Wang, Z. (2016). Three New Sesquiterpenoids and One New Sesquiterpenoid Derivative from Chinese Eaglewood. Molecules, 21(3), 281. |
[20] | Gao, X. L., Zhang, Q., Huo, H. X., et al. (2019). Agarwood essential oil exerts anti-inflammatory effects by inhibiting p-STAT3 and IL-1β/IL-6 production. Chinese Pharmaceutical Journal, 54(23), 1951-1957. |
[21] | Li, J., Chen, D., Jiang, Y., et al. (2013). Identification and quantification of 5,6,7,8-tetrahydro-2-(2-phenylethyl)chromones in Chinese eaglewood by HPLC with diode array detection. Journal of Separation Science, 36(23), 3733-3740. |
[22] | Yang, J., Dong, W., Kong, F., et al. (2016). Characterization and analysis of 2-(2-phenylethyl)-chromone derivatives from agarwood by artificial holing for different times. Molecules, 21(7), 911. |
[23] | Zhang, L., Wang, H., Dong, W. H., et al. (2023). Chemical constituents and anti-inflammatory activity of cultivated agarwood. China Herbal Medicine, 54(03), 695-703. |
[24] | Anonymous. (2015). Study on antibacterial activity components. [Doctoral dissertation, Guangdong Pharmaceutical University]. |
[25] | Peng, D. Q., Wang, C. H., Liu, Y. Y., et al. (2021). Research progress on chemical constituents and pharmacological activities of agarwood. Chinese Journal of Modern Applied Pharmacy, 38(03), 358-365. |
APA Style
Li, L., Zhou, J., Mao, C., Sunchuri, D., Yang, Z., et al. (2024). Exploration of the Effects of Agarwood Extract on the Inflammtory Microbiota in the Oral-Gut Axis. Science Journal of Public Health, 12(3), 79-82. https://doi.org/10.11648/j.sjph.20241203.13
ACS Style
Li, L.; Zhou, J.; Mao, C.; Sunchuri, D.; Yang, Z., et al. Exploration of the Effects of Agarwood Extract on the Inflammtory Microbiota in the Oral-Gut Axis. Sci. J. Public Health 2024, 12(3), 79-82. doi: 10.11648/j.sjph.20241203.13
AMA Style
Li L, Zhou J, Mao C, Sunchuri D, Yang Z, et al. Exploration of the Effects of Agarwood Extract on the Inflammtory Microbiota in the Oral-Gut Axis. Sci J Public Health. 2024;12(3):79-82. doi: 10.11648/j.sjph.20241203.13
@article{10.11648/j.sjph.20241203.13, author = {Lin-Yi Li and Jie Zhou and Cun-Hao Mao and Diwas Sunchuri and Zhuo-Da Yang and Xu-Dong Tian and Zi-Nan Zhan and Zhu-Ling Guo}, title = {Exploration of the Effects of Agarwood Extract on the Inflammtory Microbiota in the Oral-Gut Axis }, journal = {Science Journal of Public Health}, volume = {12}, number = {3}, pages = {79-82}, doi = {10.11648/j.sjph.20241203.13}, url = {https://doi.org/10.11648/j.sjph.20241203.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20241203.13}, abstract = {Agarwood, as a precious medicinal material with distinctive characteristics from Hainan, has been shown in recent studies to possess significant anti-inflammatory and antibacterial properties. With the rapid growth in public recognition of health concepts, oral health has garnered increased attention. The main focus of this study is the impact of agarwood extracts on the oral-gut axis microbiota. The relationship between the oral and gut microbiota is closely intertwined, where oral microbiota can directly colonize the intestine via saliva and other means, altering the original microbial composition of the gut and leading to dysbiosis. For instance, Porphyromonas gingivalis significantly increases in patients with gingivitis and periodontitis, as it can tolerate the acidic environment of the stomach and colonize the intestines through the gastric barrier. Therefore, oral health can affect intestinal health. Additionally, oral lesions are evident in patients with intestinal inflammation; such patients, like those with IBD, exhibit a significant accumulation of oral bacteria in the intestines. Although IBD primarily affects the intestines, its extraintestinal symptoms, often prominently displayed, include oral manifestations. Hence, intestinal health can also influence oral health. Agarwood extracts inhibit pathogenic oral microbiota, impedes their colonization in the intestine, and consequently reduces the likelihood of inflammatory bowel disease.. This article, by introducing the microbiota of periodontitis and the pathogenesis of inflammatory bowel disease, along with extraintestinal symptoms, the preventive and inhibitory mechanisms of agarwood extract on the associated microbiota are analyzed, providing new insights for the treatment of such patients. It underscores the importance of maintaining oral hygiene and preventing oral diseases as well. }, year = {2024} }
TY - JOUR T1 - Exploration of the Effects of Agarwood Extract on the Inflammtory Microbiota in the Oral-Gut Axis AU - Lin-Yi Li AU - Jie Zhou AU - Cun-Hao Mao AU - Diwas Sunchuri AU - Zhuo-Da Yang AU - Xu-Dong Tian AU - Zi-Nan Zhan AU - Zhu-Ling Guo Y1 - 2024/05/24 PY - 2024 N1 - https://doi.org/10.11648/j.sjph.20241203.13 DO - 10.11648/j.sjph.20241203.13 T2 - Science Journal of Public Health JF - Science Journal of Public Health JO - Science Journal of Public Health SP - 79 EP - 82 PB - Science Publishing Group SN - 2328-7950 UR - https://doi.org/10.11648/j.sjph.20241203.13 AB - Agarwood, as a precious medicinal material with distinctive characteristics from Hainan, has been shown in recent studies to possess significant anti-inflammatory and antibacterial properties. With the rapid growth in public recognition of health concepts, oral health has garnered increased attention. The main focus of this study is the impact of agarwood extracts on the oral-gut axis microbiota. The relationship between the oral and gut microbiota is closely intertwined, where oral microbiota can directly colonize the intestine via saliva and other means, altering the original microbial composition of the gut and leading to dysbiosis. For instance, Porphyromonas gingivalis significantly increases in patients with gingivitis and periodontitis, as it can tolerate the acidic environment of the stomach and colonize the intestines through the gastric barrier. Therefore, oral health can affect intestinal health. Additionally, oral lesions are evident in patients with intestinal inflammation; such patients, like those with IBD, exhibit a significant accumulation of oral bacteria in the intestines. Although IBD primarily affects the intestines, its extraintestinal symptoms, often prominently displayed, include oral manifestations. Hence, intestinal health can also influence oral health. Agarwood extracts inhibit pathogenic oral microbiota, impedes their colonization in the intestine, and consequently reduces the likelihood of inflammatory bowel disease.. This article, by introducing the microbiota of periodontitis and the pathogenesis of inflammatory bowel disease, along with extraintestinal symptoms, the preventive and inhibitory mechanisms of agarwood extract on the associated microbiota are analyzed, providing new insights for the treatment of such patients. It underscores the importance of maintaining oral hygiene and preventing oral diseases as well. VL - 12 IS - 3 ER -